Norac

Norac Pharma is a specialized Contract Development and Manufacturing Organization (CDMO) that provides process development and GMP manufacturing services for the pharmaceutical industry. Based in Azusa, California, the company focuses on the synthesis of complex small molecule Active Pharmaceutical Ingredients (APIs) and intermediates. Norac Pharma is well-regarded for its expertise in controlled substances (DEA Schedules I-V) and high-potency compounds. The company offers services ranging from early-stage process chemistry to commercial-scale production. In September 2017, Norac Pharma was acquired by the Italian API manufacturer Olon S.p.A. This acquisition allowed Olon to establish a significant manufacturing presence in the United States and integrate Norac's specialized chemical capabilities into its global network.